Scandion Oncology A/S SCOL.ST Stock
0.66 SEK
{{ price }}
-2.352946%
{{change_pct}}%
SECTOR
Healthcare
INDUSTRY
Biotechnology
COUNTRY
Sweden
Exchange
Stockholm
Market Cap
27.03M SEK
LOW - HIGH [24H]
0.61
-
0.68 SEK
VOLUME [24H]
183.91K SEK
{{ volume }}
P/E Ratio
0
Earnings per share
-1.42 SEK
Scandion Oncology A/S Price Chart
Scandion Oncology A/S SCOL.ST Financial and Trading Overview
| Scandion Oncology A/S stock price | 0.66 SEK |
| Previous Close | 1.39 SEK |
| Open | 1.39 SEK |
| Bid | 1.3 SEK x N/A |
| Ask | 1.38 SEK x N/A |
| Day's Range | 1.29 - 1.39 SEK |
| 52 Week Range | 1.28 - 9.37 SEK |
| Volume | 2.55K SEK |
| Avg. Volume | 59.16K SEK |
| Market Cap | 56.26M SEK |
| Beta (5Y Monthly) | 0.542638 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.42 SEK |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 3.36 SEK |
SCOL.ST Valuation Measures
| Enterprise Value | -653444 SEK |
| Trailing P/E | N/A |
| Forward P/E | -1.3037736 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 661.8479 |
| Price/Book (mrq) | 0.92194796 |
| Enterprise Value/Revenue | -7.688 |
| Enterprise Value/EBITDA | 0.008 |
Trading Information
Scandion Oncology A/S Stock Price History
| Beta (5Y Monthly) | 0.542638 |
| 52-Week Change | -84.13% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 9.37 SEK |
| 52 Week Low | 1.28 SEK |
| 50-Day Moving Average | 1.69 SEK |
| 200-Day Moving Average | 2.68 SEK |
SCOL.ST Share Statistics
| Avg. Volume (3 month) | 59.16K SEK |
| Avg. Daily Volume (10-Days) | 46.75K SEK |
| Shares Outstanding | 40.71M |
| Float | 38.26M |
| Short Ratio | N/A |
| % Held by Insiders | 1.81% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -91729.40% |
| Gross Margin | 100.00% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -55.65% |
| Return on Equity (ttm) | -95.69% |
Income Statement
| Revenue (ttm) | 85K SEK |
| Revenue Per Share (ttm) | 0.05 SEK |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -77796000 SEK |
| Net Income Avi to Common (ttm) | -73069000 SEK |
| Diluted EPS (ttm) | -2.64 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 60.19M SEK |
| Total Cash Per Share (mrq) | 1.48 SEK |
| Total Debt (mrq) | 1.4M SEK |
| Total Debt/Equity (mrq) | 2.3 SEK |
| Current Ratio (mrq) | 5.682 |
| Book Value Per Share (mrq) | 1.499 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -68965000 SEK |
| Levered Free Cash Flow (ttm) | -45581876 SEK |
Profile of Scandion Oncology A/S
| Country | Sweden |
| State | N/A |
| City | Copenhagen |
| Address | Symbion |
| ZIP | 2100 |
| Phone | 45 38 10 20 17 |
| Website | https://www.scandiononcology.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 10 |
Scandion Oncology A/S, a clinical-stage biotechnology company, develops medicines for the treatment of chemotherapy resistance. Its lead product candidate includes the SCO-101, an oral drug that is in clinical Phase Ib and Phase II studies in cancer patients. The company's other product candidate is SCO-201, which is in preclinical trial for the treatment of solid tumors. Scandion Oncology A/S was incorporated in 2017 and is headquartered in Copenhagen, Denmark.
Q&A For Scandion Oncology A/S Stock
What is a current SCOL.ST stock price?
Scandion Oncology A/S SCOL.ST stock price today per share is 0.66 SEK.
How to purchase Scandion Oncology A/S stock?
You can buy SCOL.ST shares on the Stockholm exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Scandion Oncology A/S?
The stock symbol or ticker of Scandion Oncology A/S is SCOL.ST.
Which industry does the Scandion Oncology A/S company belong to?
The Scandion Oncology A/S industry is Biotechnology.
How many shares does Scandion Oncology A/S have in circulation?
The max supply of Scandion Oncology A/S shares is 40.71M.
What is Scandion Oncology A/S Price to Earnings Ratio (PE Ratio)?
Scandion Oncology A/S PE Ratio is now.
What was Scandion Oncology A/S earnings per share over the trailing 12 months (TTM)?
Scandion Oncology A/S EPS is -1.42 SEK over the trailing 12 months.
Which sector does the Scandion Oncology A/S company belong to?
The Scandion Oncology A/S sector is Healthcare.
Scandion Oncology A/S SCOL.ST included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| First North Sweden SEK GI FNSESEKGI | 2001.34 SEK 195.36 USD |
-1.07
|
— — | 1999.37 SEK 195.16 USD | 2020.41 SEK 197.22 USD | — - | — — |
| First North Sweden EUR GI FNSEEURGI | 1616.97 EUR 1767.57 USD |
-1.5
|
— — | 1615.38 EUR 1765.82 USD | 1639.39 EUR 1792.08 USD | — - | — — |
| First North Health Care GI FN20GI | 939.04 EUR 1026.5 USD |
-1.95
|
— — | 937.79 EUR 1025.13 USD | 957.74 EUR 1046.94 USD | — - | — — |
| First North All-Share EUR FIRSTNORTHEUR | 100.98 EUR 110.38 USD |
-1.33
|
— — | 100.89 EUR 110.29 USD | 102.35 EUR 111.88 USD | — - | — — |
| First North Sweden SEK PI FNSESEKPI | 1878.6 SEK 183.37 USD |
+0.16
|
— — | 1870.08 SEK 182.54 USD | 1889.76 SEK 184.46 USD | — - | — — |
| First North Sweden EUR PI FNSEEURPI | 1513.01 EUR 1653.92 USD |
+0.67
|
— — | 1510.95 EUR 1651.67 USD | 1533.41 EUR 1676.23 USD | — - | — — |
| First North Health Care PI FN20PI | 934.74 EUR 1021.8 USD |
-1.95
|
— — | 933.5 EUR 1020.44 USD | 953.35 EUR 1042.15 USD | — - | — — |
| First North All-Share SEK FIRSTNORTHSEK | 126.34 SEK 12.33 USD |
-0.9
|
— — | 126.23 SEK 12.32 USD | 127.53 SEK 12.45 USD | — - | — — |
| First North All-Share DKK FIRSTNORTHDKK | 101.04 DKK 14.82 USD |
-1.33
|
— — | 100.96 DKK 14.8 USD | 102.42 DKK 15.02 USD | — - | — — |
- {{ link.label }} {{link}}